Medtronic (NYSE: MDT) is a leading global medical device company with a massive presence that spans more than 150 countries. Its products assist patients with over 70 different health conditions. Investing in the stock is a potentially great way to gain exposure to the healthcare industry as a whole.

Over the past five years, however, its shares have been a lackluster investment, falling by 8%. What should you do with Medtronic stock: buy, sell, or hold it?

One of the reasons this hasn't been a terribly exciting stock to own is that it's been growing at a fairly slow rate. In five years, Medtronic has averaged quarterly revenue gains of just under 2%, which isn't going to attract many growth investors.

Continue reading

Source Fool.com